Home Structural Intermediates in the Putative Pathway from the Cellular Prion Protein to the Pathogenic Form
Article
Licensed
Unlicensed Requires Authentication

Structural Intermediates in the Putative Pathway from the Cellular Prion Protein to the Pathogenic Form

  • Katja Jansen , Oliver Schäfer , Eva Birkmann , Karin Post , Hana Serban , Stanley B. Prusiner and Detlev Riesner
Published/Copyright: June 1, 2005
Biological Chemistry
From the journal Volume 382 Issue 4

Abstract

The conversion of the αhelical, protease sensitive and noninfectious form of the prion protein (PrP) into an insoluble, protease resistant, predominantly βsheeted and infectious form (PrP) is the fundamental event in prion formation. In the present work, two soluble and stable intermediate structural states are newly identified for recombinant Syrian hamster PrP(90 231) (recPrP), a dimeric αhelical state and a tetra or oligomeric, βsheet rich state. In 0.2% SDS at room temperature, recPrP is soluble and exhibits αhelical and random coil secondary structure as determined by circular dichroism. Reduction of the SDS concentration to 0.06% leads first to a small increase in αhelical content, whereas further dilution to 0.02% results in the aquisition of βsheet structure. The reversible transition curve is sigmoidal within a narrow range of SDS concentrations (0.04 to 0.02%). Size exclusion chromatography and chemical crosslinking revealed that the αhelical form is dimeric, while the βsheet rich form is tetra or oligomeric. Both the αhelical and βsheet rich intermediates are soluble and stable. Thus, they should be accessible to further structural and mechanistic studies. At 0.01% SDS, the oligomeric intermediates aggregated into large, insoluble structures as observed by fluorescence correlation spectroscopy. Our results are discussed with respect to the mechanism of PrP formation and the propagation of prions.

:
Published Online: 2005-06-01
Published in Print: 2001-04-27

Copyright © 2001 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. Vaccine Development: from Empirical Medicine to Molecularly Designed Therapy
  2. Dendritic Cells for Specific Cancer Immunotherapy
  3. Intracellular Bacteria as Targets and Carriers for Vaccination
  4. Bacteria-Mediated Transfer of Eukaryotic Expression Plasmids into Mammalian Host Cells
  5. Revealing the Potential of DNA-Based Vaccination: Lessons Learned from the Hepatitis B Virus Surface Antigen
  6. Progress toward a Malaria Vaccine: Efficient Induction of Protective Anti-Malaria Immunity
  7. Peptide Vaccines and Peptide Libraries
  8. Defined Synthetic Vaccines
  9. Antimicrobial Peptides: Properties and Applicability
  10. G-Quadruplex DNA Structures Variations on a Theme
  11. The Role of Heat Shock Proteins and Their Receptors in the Activation of the Immune System
  12. Transcriptional Repression Mediated by the KRAB Domain of the Human C2H2 Zinc Finger Protein Kox1/ZNF10 Does Not Require Histone Deacetylation
  13. Structure and Evolution of 4-Coumarate:Coenzyme A Ligase (4CL) Gene Families
  14. Inhibition of Hepatitis B Virus by Hammerhead Ribozyme Targeted to the Poly(A) Signal Sequence in Cultured Cells
  15. Chemical Accessibility of 18S rRNA in Native Ribosomal Complexes: Interaction Sites of mRNA, tRNA and Translation Factors
  16. C-Terminal Peptides of Interleukin-6 Modulate the Expression of junB Protooncogene and the Production of Fibrinogen by HepG2 Cells
  17. Proteome Analysis by Three-Dimensional Protein Separation: Turnover of Cytosolic Proteins in Hepatocytes
  18. Structural Intermediates in the Putative Pathway from the Cellular Prion Protein to the Pathogenic Form
  19. Local Variability of the Phosphoglycerate Kinase-Triosephosphate Isomerase Fusion Protein from Thermotoga maritima MSB 8
  20. Epigenetics of Latent Epstein-Barr Virus Genomes: High Resolution Methylation Analysis of the Bidirectional Promoter Region of Latent Membrane Protein 1 and 2B Genes
  21. The Cytosine N4-Methyltransferase M.PvuII Also Modifies Adenine Residues
  22. Expression of the Human Menkes ATPase in Xenopus laevis Oocytes
Downloaded on 29.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/BC.2001.081/html
Scroll to top button